Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.91 USD -4.63% Market Closed
Market Cap: 42.2m USD

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 20.4 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
287% Upside
Average
Price Target
20.4 USD
422% Upside
Highest
Price Target
26.25 USD
571% Upside
Lantern Pharma Inc. Competitors:
Price Targets
TECX
AVROBIO Inc
440% Upside
YMAB
Y-mAbs Therapeutics Inc
5% Downside
PHIL
Philogen SpA
36% Upside
ONCO
Oncopeptides AB
44% Upside
MAB
Mabion SA
12% Upside
CLYM
Climb Bio Inc
333% Upside
TLX
Telix Pharmaceuticals Ltd
106% Upside
PRQR
ProQR Therapeutics NV
329% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 20.4 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Back to Top